Loss of ELISA specificity due to biotinylation of monoclonal antibodies

被引:33
作者
Hoyer-Hansen, G
Hamers, MJAG
Pedersen, AN
Nielsen, HJ
Brünner, N
Dano, K
Stephens, RW
机构
[1] Univ Copenhagen Hosp, Finsen Lab, DK-2100 Copenhagen O, Denmark
[2] Hvidovre Hosp, Dept Surg Gastroenterol, Hvidovre, Denmark
关键词
ELISA specificity; biotinylated antibodies; biotinylation ratio; surface plasmon resonance;
D O I
10.1016/S0022-1759(99)00222-7
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
A significant degree of nonspecificity was found in ELISA determinations of soluble urokinase receptor (suPAR) in human blood plasma when biotinylated monoclonal antibodies (Mabs) were used for the detection layer. Surface plasmon resonance studies using both nonbiotinylated and biotinylated antibodies demonstrated that biotinylation reduced specific binding of the antibodies to their target antigen, suPAR. Furthermore, biotinylation produced a new interaction with unknown human plasma protein(s), unrelated to suPAR. Nonspecific interaction with plasma protein(s) was also observed after biotinylation of a Mab having no specific target antigen in human plasma and, in both cases, the level of nonspecific interaction was directly related to the degree of antibody biotinylation. These results reinforce earlier observations that biotinylation of antibodies can reduce the affinity of antibodies, but also indicate that, in addition, biotinylation can reduce the specificity of immunoassays for plasma proteins. (C) 2000 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:91 / 99
页数:9
相关论文
共 15 条
[11]   QUANTITATION OF THE RECEPTOR FOR UROKINASE PLASMINOGEN-ACTIVATOR BY ENZYME-LINKED-IMMUNOSORBENT-ASSAY [J].
RONNE, E ;
BEHRENDT, N ;
PLOUG, M ;
NIELSEN, HJ ;
WOLLISCH, E ;
WEIDLE, U ;
DANO, K ;
HOYERHANSEN, G .
JOURNAL OF IMMUNOLOGICAL METHODS, 1994, 167 (1-2) :91-101
[12]  
Sier CFM, 1998, CANCER RES, V58, P1843
[13]   Soluble urokinase plasminogen activator receptor in plasma of patients with inflammatory rheumatic disorders:: increased concentrations in rheumatoid arthritis [J].
Slot, O ;
Brünner, N ;
Locht, H ;
Oxholm, P ;
Stephens, RW .
ANNALS OF THE RHEUMATIC DISEASES, 1999, 58 (08) :488-492
[14]  
Stephens RW, 1997, CLIN CHEM, V43, P1868
[15]   Plasma urokinase receptor levels in patients with colorectal cancer:: Relationship to prognosis [J].
Stephens, RW ;
Nielsen, HJ ;
Christensen, IJ ;
Thorlacius-Ussing, O ;
Sorensen, S ;
Dano, K ;
Brünner, N .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1999, 91 (10) :869-874